These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 27602118)

  • 21. Triple-hit B-cell Lymphoma With MYC, BCL2, and BCL6 Translocations/Rearrangements: Clinicopathologic Features of 11 Cases.
    Wang W; Hu S; Lu X; Young KH; Medeiros LJ
    Am J Surg Pathol; 2015 Aug; 39(8):1132-9. PubMed ID: 25828391
    [TBL] [Abstract][Full Text] [Related]  

  • 22. T-cell/histiocyte-rich large B-cell lymphoma: a heterogeneous entity with derivation from germinal center B cells.
    Lim MS; Beaty M; Sorbara L; Cheng RZ; Pittaluga S; Raffeld M; Jaffe ES
    Am J Surg Pathol; 2002 Nov; 26(11):1458-66. PubMed ID: 12409722
    [TBL] [Abstract][Full Text] [Related]  

  • 23. De novo CD5-positive and Richter's syndrome-associated diffuse large B cell lymphomas are genotypically distinct.
    Matolcsy A; Chadburn A; Knowles DM
    Am J Pathol; 1995 Jul; 147(1):207-16. PubMed ID: 7541611
    [TBL] [Abstract][Full Text] [Related]  

  • 24. B-cell lymphomas with features intermediate between distinct pathologic entities. From pathogenesis to pathology.
    Carbone A; Gloghini A; Aiello A; Testi A; Cabras A
    Hum Pathol; 2010 May; 41(5):621-31. PubMed ID: 20398809
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epstein-Barr virus-associated anaplastic large cell variant of diffuse large B-cell-type non-Hodgkin's lymphoma with concurrent p53 protein expression.
    Hirose Y; Masaki Y; Shimoyama K; Fukushima T; Kawabata H; Ogawa N; Wano Y; Sugai S
    Int J Hematol; 2003 Jun; 77(5):499-502. PubMed ID: 12841389
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gray zone lymphoma effectively treated with cyclophosphamide, doxorubicin, vincristine, prednisolone, and rituximab chemotherapy: A case report.
    Hojo N; Nagasaki M; Mihara Y
    World J Clin Cases; 2022 Jun; 10(17):5708-5716. PubMed ID: 35979119
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cyclin D1-positive diffuse large B-cell lymphoma with IGH-CCND1 translocation and BCL6 rearrangement: a report of two cases.
    Al-Kawaaz M; Mathew S; Liu Y; Gomez ML; Chaviano F; Knowles DM; Orazi A; Tam W
    Am J Clin Pathol; 2015 Feb; 143(2):288-99. PubMed ID: 25596256
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Repeated clonal relapses in classical Hodgkin's lymphoma and the occurrence of a clonally unrelated diffuse large B cell non-Hodgkin lymphoma in the same patient.
    Thomas RK; Wickenhauser C; Kube D; Tesch H; Diehl V; Wolf J; Vockerodt M
    Leuk Lymphoma; 2004 May; 45(5):1065-9. PubMed ID: 15291369
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Morphological, immunophenotypic and molecular characterization of mature aggressive B-cell lymphomas in Chinese pediatric patients.
    Lu B; Zhou C; Yang W; Huang H; Gao Z; He Y; Liu H; Zhou X; Gong L
    Leuk Lymphoma; 2011 Dec; 52(12):2356-64. PubMed ID: 21740296
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Methylation profiling of mediastinal gray zone lymphoma reveals a distinctive signature with elements shared by classical Hodgkin's lymphoma and primary mediastinal large B-cell lymphoma.
    Eberle FC; Rodriguez-Canales J; Wei L; Hanson JC; Killian JK; Sun HW; Adams LG; Hewitt SM; Wilson WH; Pittaluga S; Meltzer PS; Staudt LM; Emmert-Buck MR; Jaffe ES
    Haematologica; 2011 Apr; 96(4):558-66. PubMed ID: 21454882
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinicopathologic consensus study of gray zone lymphoma with features intermediate between DLBCL and classical HL.
    Pilichowska M; Pittaluga S; Ferry JA; Hemminger J; Chang H; Kanakry JA; Sehn LH; Feldman T; Abramson JS; Kritharis A; Hernandez-Ilizaliturri FJ; Lossos IS; Press OW; Fenske TS; Friedberg JW; Vose JM; Blum KA; Jagadeesh D; Woda B; Gupta GK; Gascoyne RD; Jaffe ES; Evens AM
    Blood Adv; 2017 Dec; 1(26):2600-2609. PubMed ID: 29296913
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lymphocyte depleted Hodgkin lymphoma: an evaluation with immunophenotyping and genetic analysis.
    Slack GW; Ferry JA; Hasserjian RP; Sohani AR; Longtine JA; Harris NL; Zukerberg LR
    Leuk Lymphoma; 2009 Jun; 50(6):937-43. PubMed ID: 19455461
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Occurrence of Secondary Non-Hodgkin Lymphomas Among Our Classical Hodgkin Lymphoma Patients: A Single-Centre Experience.
    Virga B; Pinczés L; Illés Á; Miltényi Z; Magyari F; Méhes G; Simon Z
    Cureus; 2024 Jun; 16(6):e63307. PubMed ID: 39070524
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Challenges in the Diagnosis of Gray Zone Lymphomas.
    Parker K; Venkataraman G
    Surg Pathol Clin; 2019 Sep; 12(3):709-718. PubMed ID: 31352983
    [TBL] [Abstract][Full Text] [Related]  

  • 35. IgVH mutational status and clonality analysis of Richter's transformation: diffuse large B-cell lymphoma and Hodgkin lymphoma in association with B-cell chronic lymphocytic leukemia (B-CLL) represent 2 different pathways of disease evolution.
    Mao Z; Quintanilla-Martinez L; Raffeld M; Richter M; Krugmann J; Burek C; Hartmann E; Rudiger T; Jaffe ES; Müller-Hermelink HK; Ott G; Fend F; Rosenwald A
    Am J Surg Pathol; 2007 Oct; 31(10):1605-14. PubMed ID: 17895764
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Aggressive B cell lymphomas in the 2017 revised WHO classification of tumors of hematopoietic and lymphoid tissues.
    Grimm KE; O'Malley DP
    Ann Diagn Pathol; 2019 Feb; 38():6-10. PubMed ID: 30380402
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical Significance of
    Ting CY; Chang KM; Kuan JW; Sathar J; Chew LP; Wong OJ; Yusuf Y; Wong L; Samsudin AT; Pana MNBM; Lee SK; Gopal NSR; Puri R; Ong TC; Bahari SK; Goh AS; Teoh CS
    Int J Med Sci; 2019; 16(4):556-566. PubMed ID: 31171907
    [No Abstract]   [Full Text] [Related]  

  • 38. Epstein-Barr virus-positive diffuse large B-cell lymphoma in children: a disease reminiscent of Epstein-Barr virus-positive diffuse large B-cell lymphoma of the elderly.
    Uccini S; Al-Jadiry MF; Scarpino S; Ferraro D; Alsaadawi AR; Al-Darraji AF; Moleti ML; Testi AM; Al-Hadad SA; Ruco L
    Hum Pathol; 2015 May; 46(5):716-24. PubMed ID: 25704629
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gray zone lymphomas in pediatric patients.
    Liang X; Greffe B; Cook B; Giller R; Graham DK; McGranahan AN; Wang M
    Pediatr Dev Pathol; 2011; 14(1):57-63. PubMed ID: 20331368
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Among diffuse large B-cell lymphomas, T-cell-rich/histiocyte-rich BCL and CD30+ anaplastic B-cell subtypes exhibit distinct clinical features.
    Maes B; Anastasopoulou A; Kluin-Nelemans JC; Teodorovic I; Achten R; Carbone A; De Wolf-Peeters C;
    Ann Oncol; 2001 Jun; 12(6):853-8. PubMed ID: 11484964
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.